中文

健帆生物 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-28
ItemAmountY/Y
Revenue¥0.56B+2.3%
Gross profit¥0.43B
Operating income¥0.26B
Net income¥0.22B+17.3%
Gross margin77.3%Net margin 39.4%
Revenue Q/Q+23.0%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.13B22.7%
R&D¥0.05B8.1%
SG&A¥0.12B20.6%
Tax & other¥0.04B7.2%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

领湃科技优博讯今天国际冰川网络陇神戎发达威股份农尚环境广信材料同益股份横河精密蜀道装备先进数通

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies